Aug 11, 2019Biosimilars following same pattern as generics? Neupogen keeps just 6% of EU market after 10 years.Twelve years after the launch of the first biosimilar in Europe, there are still limited data available on the medium-term impact of the...
May 23, 2019Parallel trading get 30% of branded products to Big Pharma in German market after patent expiration.A sub-study from the report “German generics market 2016-2018” recently published by Emergpharma shows interesting facts regarding the...
May 8, 2019Notes on the German generics and biosimilars market 2016-2018.German generics market is the biggest in Europe in terms of values and units. It is also one of the most dynamic and with the largest...
